Industry News

Jan 24, 2018
By BioPharm International Editors
The agencies sent warning letters to several companies that the agencies say are illegally marketing unapproved products to treat opioid addiction and withdrawal.
Jan 23, 2018
By BioPharm International Editors
The agency is sending a survey out to pharmaceutical companies in the UK to gain information on their preparedness for Brexit.
Jan 23, 2018
By BioPharm International Editors
The FDA center released its list of planned guidance documents for the rest of the year.
Jan 23, 2018
By BioPharm International Editors
The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.
Jan 23, 2018
By BioPharm International Editors
The latest continuing resolution funds the government for three weeks.
Jan 22, 2018
By BioPharm International Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 19, 2018
By BioPharm International Editors
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
Jan 18, 2018
By BioPharm International Editors
Researchers at Purdue University and and industry experts have partnered up at the Advanced Lyophilization Technology Hub to optimize the 70-year-old freeze-drying process.
Jan 17, 2018
By BioPharm International Editors
The company has expanded its voluntary nationwide recall to include a second lot of Nexterone injection. This recall is due to particulate matter found in the product.
Jan 16, 2018
By BioPharm International Editors
The agency has expanded the indication of AstraZeneca’s anti-cancer drug to include treatment for breast cancer with a certain inherited genetic mutation.
native1_300x100
lorem ipsum